Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study
TIGER
1 other identifier
interventional
146
1 country
1
Brief Summary
To compare the frequency of regurgitation and other digestive outcomes between infants who receive an infant formula based on whole goat milk and an infant formula based on cow milk proteins during the transition period from breastfeeding to formula feeding, using predominantly breastfed infants as a reference group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2022
CompletedFirst Posted
Study publicly available on registry
May 6, 2022
CompletedStudy Start
First participant enrolled
May 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2024
CompletedSeptember 19, 2024
September 1, 2024
1.9 years
April 21, 2022
September 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in daily frequency of regurgitation during the transition period from breastfeeding to formula feeding
Parental diary record of number of regurgitation per day reviewed at Day 0, Day 14 and Day 28
From Day 0 to Day 28
Secondary Outcomes (10)
Frequency of infant regurgitation
Day 0, Day 14, Day 28, and Age 8, 12, 16, 20 and 24 weeks
Frequency of infant colic
Day 0, Day 14, Day 28, and Age 8, 12, 16, 20 and 24 weeks
Frequency of functional constipation
Day 0, Day 14, Day 28, and Age 8, 12, 16, 20 and 24 weeks
Stool consistency
Day 0, Day 14, Day 28, and Age 8, 12, 16, 20 and 24 weeks
Stool frequency
Day 0, Day 14, Day 28, and Age 8, 12, 16, 20 and 24 weeks
- +5 more secondary outcomes
Study Arms (3)
infant formula based on whole goat milk
EXPERIMENTALInfant formula based on cow milk proteins
ACTIVE COMPARATORPredominantly breastmilk
NO INTERVENTIONInterventions
Infant formula based on whole goat milk, nutritionally suitable for infants aged 0-6 months
Infant formula based on cow milk proteins, nutritionally suitable for infants aged 0-6 months
Eligibility Criteria
You may qualify if:
- healthy full-term born infants (≥ 37 weeks + 0 days and \< 41 weeks + 6 days of gestation)
- birth weight ≥ 2.5 kg and ≤ 4.5 kg
- born from a singleton pregnancy
- live in Bangkok or nearby with no plan for geographical migration before 6 months of age
- for experimental and active comparator groups only: parent(s) has expressed the intention to partially (in combination with breastfeeding) or fully formula-feed the infant and ready to enroll in the study before the age of 4 months/120 days
- for no intervention group only: parent(s) has expressed the intention to predominantly breastfeed (according to study definition) and ready to enroll in the study before the age of 4 months/120 days
- infant has been predominantly breastfed for at least 2 weeks before enrollment
- parent(s) has sufficient Thai language skills to understand the study information, the informed consent, and to comply with the study procedure
- parent(s) is willing and deemed able to fulfil the requirements of the study protocol and procedures
- at least one parent is of legal age of consent
You may not qualify if:
- infant has any disorder considered to interfere with nutrition, growth or development of the immune system
- participation of the infant in any other interventional trial or participation of the mother in any intervention trial with infant follow-up
- for experimental and active comparator groups only: infant has been formula-fed for more than 1 week before enrolment
- for experimental and active comparator groups only: cow milk allergy or intolerance of the infant
- for experimental and active comparator groups only: enrolled infant who never consumed any study product until the first visit 2 weeks following enrolment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dairy Goat Co-operative (N.Z.) Limitedlead
- Chulalongkorn Universitycollaborator
Study Sites (1)
Pediatric Nutrition Research Unit, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital
Bangkok, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sirinuch Chomtho, MD, PhD
Chulalongkorn University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Quadrupole
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2022
First Posted
May 6, 2022
Study Start
May 25, 2022
Primary Completion
April 30, 2024
Study Completion
August 28, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09